Aim: To compare the performance of three different screening methods (National Institute for Health and Clinical Excellence (NICE) guidelines, American College of Obstetricians and Gynecologists (ACOG) recommendations and Fetal Medicine Foundation (FMF) algorithm) for second trimester prediction of preeclampsia.
Methods: This was a prospective non-intervention study in singleton pregnancies, including women attending for second trimester morphologic ultrasound at 19-22 weeks. Maternal characteristics, medical history, mean arterial pressure and mean uterine artery Doppler pulsatility index were recorded and used for risk assessment. Outcomes measured were preeclampsia with delivery before 34, before 37 and after 37 weeks gestation. Detection rates, false positive rates and positive likelihood ratios were calculated, and receiver operating characteristic curves were produced.
Results: We screened 543 women during the study. The incidence of preeclampsia before 34, before 37 and after 37 weeks was 0.5, 1.4 and 3.4%, respectively. Detection rates for prediction of preterm preeclampsia were 75% (95% CI 34.9-96.8), 87% (95% CI 47.3-99.6), 100% (95% CI 63.0-100) and 100% (95% CI 63.0-100) for NICE guidelines, ACOG recommendations, FMF algorithm with a 1:100 cut-off and FMF algorithm at 1:60 cut-off, respectively. False positive rates were, 22, 67, 19 and 12% for NICE guidelines, ACOG recommendations, FMF algorithm with a 1:100 cut-off and FMF algorithm at 1:60 cut-off, respectively.
Conclusion: Second trimester combined screening for preterm preeclampsia by maternal history, mean arterial pressure and mean uterine artery Doppler pulsatility index (FMF algorithm) was superior to screening by maternal factors alone (NICE guidelines and ACOG recommendations).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ajo.12689 | DOI Listing |
Expert Opin Drug Saf
December 2024
Department of Cardiology, Intervention Cardiology Center, Wuhan No.1 Hospital, Wuhan, China.
Background: Colchicine is widely used for gout and familial Mediterranean fever (FMF) and has cardiovascular benefits. However, it is linked to various adverse drug reactions (ADRs). This study aimed to analyze colchicine-related ADRs using FAERS data for safer clinical use.
View Article and Find Full Text PDFGynecol Obstet Fertil Senol
October 2024
Service de gynécologie obstétrique, CHU Toulouse, Toulouse, France; Centre d'Epidémiologie et de Recherche en Santé des Populations (CERPOP), UMR1295, Université Paul Sabatier University, Toulouse, France.
Pediatr Rheumatol Online J
August 2024
Department of Pediatrics, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Background: Artificial intelligence (AI) has become a popular tool for clinical and research use in the medical field. The aim of this study was to evaluate the accuracy and reliability of a generative AI tool on pediatric familial Mediterranean fever (FMF).
Methods: Fifteen questions repeated thrice on pediatric FMF were prompted to the popular generative AI tool Microsoft Copilot with Chat-GPT 4.
Rheumatology (Oxford)
May 2024
Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Cureus
April 2024
Obstetrics and Gynaecology, Thai Nguyen National Hospital, Thai Nguyen, VNM.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!